Sign In
Buy VIR
$8.66
-0.240 (-2.70%)
At Close: Jul 31, 2026
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vir Biotechnology, Inc. - VIR
09:21pm, Sunday, 14'th Mar 2021
New York, New York--(Newsfile Corp. - March 14, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Vir Biotechnology, Inc. ("Vir" or the "Company") (NASDAQ: VIR). Such investors a
Vir Biotechnology, Inc. (VIR) Surges 32.1%: Is This an Indication of Further Gains?
08:44am, Friday, 12'th Mar 2021
Vir Biotechnology, Inc. (VIR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be m
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vir Biotechnology, Inc. - VIR
06:20am, Friday, 12'th Mar 2021
NEW YORK, March 12, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Vir Biotechnology, Inc. ("Vir" or the "Company") (NASDAQ: VIR). Such investors are adv
Why Vir Biotechnology Stock Soared Today
05:12pm, Thursday, 11'th Mar 2021
Investors are excited about the potential of the company's investigational coronavirus therapy.
VIR Biotech CEO on its positive Covid antibody drug results
11:34am, Thursday, 11'th Mar 2021
CNBC's Meg Tirrell discusses VIR Biotechnology's antibody drug results and what it can do to aid the Covid pandemic with VIR Biotech CEO George Scangos.
VIR Stock Price Increases Over 50% Pre-Market: Why It Happened
07:12am, Thursday, 11'th Mar 2021
The stock price of Vir Biotechnology Inc (NASDAQ: VIR) has increased by over 50% pre-market. This is why it happened.
Vir/GSK's COVID-19 Antibody Therapy Cuts Hospitalization, Deaths by 85%, Seeks FDA Emergency Use Nod
05:13am, Thursday, 11'th Mar 2021
An Independent Data Monitoring Committee (IDMC) has recommended that the Phase 3 COMET-ICE trial, evaluating VIR-7831 (GSK4182136) as monotherapy for COVID-19, stop enrollment due to evidence of pro
Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treatment of Adults with COVID-19
08:22pm, Wednesday, 10'th Mar 2021
– Independent Data Monitoring Committee recommends stopping Phase 3 COMET-ICE trial early given an 85% reduction in hospitalization or death –
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vir Biotechnology, Inc. - VIR
08:55pm, Sunday, 07'th Mar 2021
New York, New York--(Newsfile Corp. - March 7, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Vir Biotechnology, Inc. ("Vir" or the "Company") (NASDAQ: VIR). Such investors ar
After 2 Licensing Deals Will GlaxoSmithKline Acquire Vir?
09:00am, Saturday, 06'th Mar 2021
The relationship could result in a marriage down the line.
Why Vir Biotechnology Stock Is Falling Today
12:52pm, Thursday, 04'th Mar 2021
Bearish commentary from an analyst may be to blame.
Are Options Traders Betting on a Big Move in Vir Biotechnology (VIR) Stock?
09:08am, Thursday, 04'th Mar 2021
Investors need to pay close attention to Vir Biotechnology (VIR) stock based on the movements in the options market lately.
VIR Stock: Why Vir Biotechnology Is Plunging Today
02:58pm, Wednesday, 03'rd Mar 2021
VIR stock is plunging on some pretty unfavorable news about a trial being suspended for the company's prospective Covid-19 vaccine. The post VIR Stock: Why Vir Biotechnology Is Plunging Today appeared
Vir Shares Plummeted Today. What to Know.
02:57pm, Wednesday, 03'rd Mar 2021
The company announced that a data and safety monitoring board had recommended ending a trial of its experimental antibody therapy in hospitalized Covid-19 patients.
Why Vir Biotechnology Stock Is Dropping Today
12:55pm, Wednesday, 03'rd Mar 2021
The company provided a discouraging regulatory update.
